Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching

PURPOSE: The impact of transarterial chemoembolization after initiation of sorafenib (SOR) has not been prospectively compared with SOR alone in unresectable hepatocellular carcinoma (HCC). The objective of this study was to assess whether SOR + transarterial chemoembolization provides benefit over...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Vasc Interv Radiol
Principais autores: Kaplan, David E., Mehta, Rajni, D’Addeo, Kathryn, Gade, Terence P., Taddei, Tamar H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6104514/
https://ncbi.nlm.nih.gov/pubmed/29477619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2017.11.033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados